MAP1A Gene Hearing Loss MAP1A Related Genetic Test sale cost 4400 AED
PNPT1 Gene Deafness Autosomal Recessive Type 70 Genetic Test sale cost 4400 AED PNPT1 Gene Deafness Autosomal Recessive Type 70 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test sale cost 4400 AED CFAP298 Gene Primary Ciliary Dyskinesia Type 26 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

MAP1A Gene Hearing Loss MAP1A Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MAP1A gene is known to play a critical role in the development and function of the inner ear, which is crucial for hearing. Mutations in the MAP1A gene can lead to various forms of hearing loss, making it a significant focus for genetic testing in individuals experiencing auditory issues without a clear cause. The MAP1A-related genetic test is a specialized diagnostic tool designed to identify mutations within the MAP1A gene that might be responsible for hearing loss. This test is particularly valuable for individuals with a family history of hearing loss or those who have hearing loss with an unknown etiology.

Conducted at DNA Labs UAE, the test offers a comprehensive analysis of the MAP1A gene, utilizing advanced genetic sequencing technologies to ensure accurate and reliable results. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations that could be linked to hearing loss.

The cost of the MAP1A-related genetic test at DNA Labs UAE is 4400 AED. This price includes the cost of sample collection, genetic analysis, and the provision of a detailed report that explains the results. The report not only offers insights into the genetic status of the MAP1A gene but also provides valuable information for healthcare providers to develop a personalized management or treatment plan for the affected individual.

This test is a crucial step towards understanding the genetic basis of hearing loss in affected individuals and can significantly impact the management and treatment of the condition, offering a pathway towards improved quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MAP1A Gene Hearing Loss MAP1A Related Genetic Test

Welcome to DNA Labs UAE, where we offer the MAP1A gene hearing loss MAP1A related genetic test. This test can help in diagnosing the cause of hearing loss in individuals and provide valuable information for genetic counseling and treatment.

Test Details

The MAP1A (Microtubule-associated protein 1A) gene is responsible for encoding a protein involved in the organization and stabilization of microtubules, which are important for the structure and function of cells. Mutations in the MAP1A gene have been associated with various neurological disorders, including hearing loss.

The MAP1A-related NGS (Next-Generation Sequencing) genetic test is a type of genetic test that uses advanced sequencing technology to analyze the DNA sequence of the MAP1A gene. This test can identify any variations or mutations in the gene that may be associated with hearing loss or other related conditions.

Components and Price

The price of the MAP1A gene hearing loss MAP1A related genetic test is 4400.0 AED. The test requires a blood or extracted DNA sample, or one drop of blood on an FTA card.

Report Delivery

The report for the MAP1A gene hearing loss MAP1A related genetic test is typically delivered within 3 to 4 weeks.

Method and Test Type

The MAP1A gene hearing loss MAP1A related genetic test utilizes NGS (Next-Generation Sequencing) technology for analysis. This advanced sequencing technology allows for a comprehensive examination of the DNA sequence of the MAP1A gene.

The test falls under the category of Ear Nose Throat Disorders.

Doctor and Test Department

The MAP1A gene hearing loss MAP1A related genetic test is typically ordered by an ENT (Ear Nose Throat) doctor. The test is conducted in the Genetics department of our laboratory.

Pre Test Information

Prior to the MAP1A gene hearing loss MAP1A related genetic test, it is important to provide the clinical history of the patient. This includes information about any CATSPER2 gene deafness and male infertility, as well as any related NGS genetic DNA tests. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected with CATSPER2 gene deafness and male infertility.

It is worth mentioning that the gene CATSPER14 may also be involved in the test.

In conclusion, the MAP1A gene hearing loss MAP1A related genetic test offered by DNA Labs UAE is a valuable tool for diagnosing the cause of hearing loss. By analyzing the DNA sequence of the MAP1A gene, this test can identify variations or mutations that may be associated with hearing loss or other related conditions. It provides important information for genetic counseling, treatment, and management. If you suspect a genetic basis for your hearing loss, consult with a healthcare professional specialized in genetic conditions, such as a geneticist or an otolaryngologist, to determine if the MAP1A gene hearing loss MAP1A related genetic test is right for you.

Test Name MAP1A Gene Hearing loss MAP1A related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CATSPER2 Gene Deafness and male infertility, CATSPER2 related NGS Genetic DNA Test gene CATSPER14
Test Details

MAP1A (Microtubule-associated protein 1A) is a gene that encodes a protein involved in the organization and stabilization of microtubules, which are important for the structure and function of cells. Mutations in the MAP1A gene have been associated with various neurological disorders, including hearing loss.

A MAP1A-related NGS (Next-Generation Sequencing) genetic test is a type of genetic test that uses advanced sequencing technology to analyze the DNA sequence of the MAP1A gene. This test can identify any variations or mutations in the gene that may be associated with hearing loss or other related conditions.

By identifying specific mutations in the MAP1A gene, this genetic test can help in diagnosing the cause of hearing loss in individuals. It can also provide valuable information for genetic counseling and assist in determining the best course of treatment or management for affected individuals.

It’s important to note that a genetic test for MAP1A-related hearing loss is typically ordered by a healthcare professional, such as a geneticist or an otolaryngologist, who specializes in the diagnosis and management of genetic conditions. The test may involve collecting a blood or saliva sample from the individual, which is then sent to a specialized laboratory for analysis.

Overall, a MAP1A-related NGS genetic test can help in understanding the genetic basis of hearing loss and provide important information for diagnosis, treatment, and genetic counseling.

SKU: TEST-2753 Category:

Related products